ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis
- 30 September 1996
- journal article
- research article
- Published by Elsevier in Current Biology
- Vol. 6 (9) , 1192-1195
- https://doi.org/10.1016/s0960-9822(02)70688-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.The Journal of Experimental Medicine, 1995
- The Baculovirus p35 Protein Inhibits Fas- and Tumor Necrosis Factor-induced ApoptosisPublished by Elsevier ,1995
- Apoptosis and hepatobiliary diseaseHepatology, 1995
- Involvement of an ICE-like protease in Fas-mediated apoptosisNature, 1995
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene ProductJournal of Biological Chemistry, 1995
- Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.Genes & Development, 1994
- Lethal effect of the anti-Fas antibody in miceNature, 1993
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992